PTEN and neoplasm: In this sense, IHC appears to be a better approach for the evaluation of PTEN protein expression in canine tumors than immunoblotting, as it allows the evaluation of the topographic distribution of the protein within the tumor and its expression in tumor cells, excluding protein expression in non-tumoral tissue.